Here, we identified fibulin-4 (FBLN4), also known as EFEMP2, as the protein target for BLMP6 binding and show that FBLN4 is highly expressed in invasive and metastatic human breast cancer. This evidence concerns the gene EFEMP2 and breast carcinoma.